Company Filing History:
Years Active: 2006
Title: John Gebe: Innovator in Autoimmune Research
Introduction
John Gebe is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of autoimmune research through his innovative methods and technologies. His work focuses on the detection and treatment of autoimmune conditions, which has the potential to improve patient outcomes.
Latest Patents
John Gebe holds a patent for "Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment." This invention provides methods for using multimeric MHC class II/peptide complexes. It includes techniques for identifying MHC class II-restricted immune epitopes of predetermined polypeptide antigens. Additionally, the patent outlines methods for screening therapeutic polypeptide agents for MHC class II epitopes and modulating T cells. It also offers ways to determine or monitor the MHC class II-restricted immune status of patients.
Career Highlights
John Gebe is affiliated with the Benaroya Research Institute at Virginia Mason, where he continues to advance research in autoimmune diseases. His work is instrumental in developing new therapeutic strategies that can lead to better management of autoimmune conditions.
Collaborations
Throughout his career, John has collaborated with esteemed colleagues such as William W. Kwok and Gerald Nepom. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
John Gebe's contributions to autoimmune research through his patent and work at the Benaroya Research Institute highlight his commitment to improving healthcare. His innovative methods pave the way for advancements in the detection and treatment of autoimmune diseases.